Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study

Fig. 3

Survival of patients with both low SMI (sarcopenia) and low SMD compared to other patients. Group A: High SMI and high SMD; Group B: High SMI and low SMD; Group C: Low SMI and high SMD; Group D: Low SMI and low SMD. Patients with low SMI and low SMD showed poorer overall survival than those with either of these conditions or neither one (a, c). Copresence of low SMI and low SMD were not associated with progression-free survival (b, d)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us